Neurosteroid treatment of postpartum depression and beyond.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 40470759.
- Also identified by DOI 10.1192/bjp.2025.90.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Depression occurring during pregnancy or after delivery is one of the most common complications of childbirth and is associated with maternal morbidity and mortality. Here we review the breakthrough development of the first neuroactive steroid-based antidepressants approved for postpartum depression in the USA and their potential in other psychiatric illnesses.
Medical subject headings
- Depression, Postpartum
- Antidepressive Agents
- Neurosteroids